Correspondence 0001213900-23-023227 from G Medical Innovations Holdings Ltd. (GMVDF) (CIK 0001760764)
G Medical Innovations Holdings Ltd. (GMVDF) (CIK 0001760764)
Date: March 27, 2023 · CIK: 0001760764 · Accession: 0001213900-23-023227
AI Filing Summary & Sentiment
File numbers found in text: 333-269496
Letter
ThinkEquity LLC
17 State Street, 41st Fl
New York, NY 10004
March 27, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 3030
Washington, D.C. 20549
Re: G Medical Innovations Holdings Ltd
Registration Statement on Form F-1, as amended
Filed February 1, 2023
File No. 333-269496
Ladies and Gentlemen:
In connection with the Registration Statement on Form F-1 of G Medical Innovations Holdings Ltd., the undersigned, which is acting as the representative of the underwriters of the offering, hereby requests acceleration of the effective date and time of the Registration Statement to 5:00 p.m., Eastern Time, on March 29, 2023, or as soon thereafter as practicable, pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Act”).
Pursuant to Rule 460 under the Securities Act, please be advised that there will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended.
Very truly yours,
ThinkEquity LLC
Show Raw Text
CORRESP
1
filename1.htm
ThinkEquity LLC
17 State Street, 41st Fl
New York, NY 10004
March 27, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Mail Stop 3030
Washington, D.C. 20549
Re:
G Medical Innovations Holdings Ltd
Registration Statement on Form F-1, as amended
Filed February 1, 2023
File No. 333-269496
Ladies and Gentlemen:
In connection with the Registration
Statement on Form F-1 of G Medical Innovations Holdings Ltd., the undersigned, which is acting as the representative of the underwriters
of the offering, hereby requests acceleration of the effective date and time of the Registration Statement to 5:00 p.m., Eastern Time,
on March 29, 2023, or as soon thereafter as practicable, pursuant to Rule 461 of the Securities Act of 1933, as amended (the “Act”).
Pursuant to Rule 460 under the Securities Act, please be advised that there
will be distributed to each underwriter, who is reasonably anticipated to be invited to participate in the distribution of the security,
as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary
prospectus.
The undersigned advises that it has complied and
will continue to comply with the requirements of Rule 15c2-8 under the Securities and Exchange Act of 1934, as amended.
Very truly yours,
ThinkEquity LLC
By:
/s/ Eric Lord
Name:
Eric Lord
Title:
Head of Investment Banking